Close

2016 BIO International Convention Adds More Events to Already Robust Program

BIO announced that two additional Fireside Chats will be added to the 2016 BIO International Convention program. Also announced, were the winners of its “Future Makers in Biotech” contest in which individuals were nominated by their peers for vision, innovation, and advancements in biotechnology. 

BIO Business Solutions Extends Agreement with VWR

Washington, D.C. (June 1, 2016) – Today, the Biotechnology Innovation Organization (BIO) announced a new agreement with VWR to provide members with laboratory supplies, equipment and chemicals through June 2023.

Ambassador Darci Vetter to Keynote Food and Ag Track at 2016 BIO International Convention

BIO has officially announced that Ambassador Darci Vetter, Chief Agricultural Negotiator of the Office of the U.S. Trade Representative, will deliver the keynote address during the Food and Agriculture track at the 2016 BIO International Convention.  BIO 2016 will be held June 6-9, 2016 in San Francisco, California at the Moscone Center.

BIO Applauds Reps. Sean Duffy and John Carney for Introducing the Corporate Governance Reform and Transparency Act

Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Sean Duffy (R-WI) and John Carney (D-DE) for introducing the Corporate Governance Reform and Transparency Act. 

BIO Releases Largest Study Ever on Clinical Development Success Rates

Today, the Biotechnology Innovation Organization (BIO) released the largest study ever of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success.

BIO Applauds House Passage of the Fostering Innovation Act

BIO applauds the US House of Representatives for passing H.R. 4139, the Fostering Innovation Act.  The bipartisan legislation was introduced by Reps. Kyrsten Sinema (D-AZ) and Michael Fitzpatrick (R-PA).

Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

The Biotechnology Innovation Organization (BIO) and Arizona BioIndustry Association (AZBio) commend Governor Doug Ducey for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Disappointed in Approps Action to Label GE Salmon

Senate Ag Committee Efforts Will Better Address Transparency Washington, D.C. (May 19, 2016) – During markup of the FY17 Agriculture Appropriations Bill, the Senate Appropriations Committee approved today by voice vote an amendment to mandate the identification of genetically engineered salmon as “genetically engineered” or “GE” in the marketplace. 

BIO Letter to Senate Appropriations Leadership on Efforts to Label Foods Produced Through Biotechnology Such As the Genetically Engineered Salmon

The Biotechnology Innovation Organization (BIO) urges you and all members of the Senate Appropriations Committee to support a national bioengineered food labeling legislative solution, which Senators Pat Roberts (R-KS) and Debbie Stabenow (D-MI) are currently crafting in the Senate Agriculture Committee, and to reject all efforts to establish unique labeling requirements for specific bioengineered food products, such as salmon, during consideration of the Fiscal Year 2017 spending bills.

BIO Releases Investment and Deal Making Study Showing Record-Breaking Year for US Venture Capital Funding of Biotech

Today, the Biotechnology Innovation Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2006-2015) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions.